NO914071L - Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser

Info

Publication number
NO914071L
NO914071L NO91914071A NO914071A NO914071L NO 914071 L NO914071 L NO 914071L NO 91914071 A NO91914071 A NO 91914071A NO 914071 A NO914071 A NO 914071A NO 914071 L NO914071 L NO 914071L
Authority
NO
Norway
Prior art keywords
preparation
procedure
therapeutic active
relations
formula
Prior art date
Application number
NO91914071A
Other languages
English (en)
Other versions
NO914071D0 (no
Inventor
Jonathan Frost
Patrick Lardenois
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO914071D0 publication Critical patent/NO914071D0/no
Publication of NO914071L publication Critical patent/NO914071L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

^. Forbindelser med generell formel (I). hvori X er en gruppe med formel CO eller CHOH, i form av frie baser eller deres syreaddisjonssalter, og når X er en gruppe med formel CHOH, i form av rene enantiomerer eller blandinger av enantiomerer.Fremgangsmåten for denne fremstilling er beskrevet. Forbindelsene har terapeutisk anvendelse.
NO91914071A 1990-10-18 1991-10-17 Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser NO914071L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9012872A FR2668149B1 (fr) 1990-10-18 1990-10-18 Le 1-(3,4-dihydro-2-oxo-1h-quinolein-6-yl)-2-[4-(2-phenyl-ethyl)piperidin-1-yl]ethanol, sa preparation et son application en therapeutique.

Publications (2)

Publication Number Publication Date
NO914071D0 NO914071D0 (no) 1991-10-17
NO914071L true NO914071L (no) 1992-04-21

Family

ID=9401336

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91914071A NO914071L (no) 1990-10-18 1991-10-17 Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser

Country Status (18)

Country Link
US (1) US5212181A (no)
EP (1) EP0481853A1 (no)
JP (1) JPH04257579A (no)
KR (1) KR920008029A (no)
AU (1) AU638173B2 (no)
CA (1) CA2052760A1 (no)
CS (1) CS315291A3 (no)
FI (1) FI914906A (no)
FR (1) FR2668149B1 (no)
HU (1) HUT59391A (no)
IE (1) IE913653A1 (no)
IL (1) IL99779A0 (no)
MX (1) MX9101604A (no)
NO (1) NO914071L (no)
NZ (1) NZ240261A (no)
PL (1) PL292089A1 (no)
PT (1) PT99247A (no)
ZA (1) ZA918293B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0524846A1 (fr) * 1991-06-27 1993-01-27 Synthelabo Dérivés de 2-(pipéridin-1-y1) éthanol, leur préparation et leur application en thérapeutique
US6255322B1 (en) * 1992-06-19 2001-07-03 Pfizer Inc. 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
JP2686887B2 (ja) * 1992-08-11 1997-12-08 キッセイ薬品工業株式会社 ピペリジノ−３，４−ジヒドロカルボスチリル誘導体
FR2699534B1 (fr) * 1992-12-21 1995-02-03 Synthelabo Dérivés de alpha-thiényl-pipéridine-1-éthanol, leur préparation et leur application en thérapeutique.
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610736B (en) 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
AU7474998A (en) * 1997-05-07 1998-11-27 Emory University Haloisoquinoline carboxamide
WO2004011430A1 (ja) * 2002-07-25 2004-02-05 Yamanouchi Pharmaceutical Co., Ltd. ナトリウムチャネル阻害剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
FR2668149A1 (fr) 1992-04-24
NO914071D0 (no) 1991-10-17
AU638173B2 (en) 1993-06-17
IE913653A1 (en) 1992-04-22
US5212181A (en) 1993-05-18
AU8589291A (en) 1992-04-30
HUT59391A (en) 1992-05-28
JPH04257579A (ja) 1992-09-11
NZ240261A (en) 1993-01-27
EP0481853A1 (fr) 1992-04-22
IL99779A0 (en) 1992-08-18
FR2668149B1 (fr) 1994-09-23
FI914906A0 (fi) 1991-10-17
FI914906A (fi) 1992-04-19
PT99247A (pt) 1992-08-31
ZA918293B (en) 1992-07-29
HU913267D0 (en) 1992-01-28
CS315291A3 (en) 1992-05-13
CA2052760A1 (en) 1992-04-19
KR920008029A (ko) 1992-05-27
MX9101604A (es) 1992-06-05
PL292089A1 (en) 1992-06-26

Similar Documents

Publication Publication Date Title
IE781878L (en) Imidazole derivatives
NO153568C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive amidinderivater.
ZA853504B (en) Pyridazinones,preparation process thereof and utilization thereof,drugs containing pyridazinones
FI870421A (fi) Analogiamenetelmä alkueläintenvastaisesti vaikuttavien 5,6-dihydro-2-(substituoitu fenyyli)-1,2,4-triatsiini-3,5(2H,4H)-dionijohdannaisten valmistamiseksi
DE68901153D1 (de) Derivate von purin, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
NO166126C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
EP0265514A4 (en) Drugs for the inhibition of ridicule.
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
NO914071L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
ES472847A1 (es) Procedimiento para la preparacion de la 2-bromoergosina y sus sales acidas de adicion
SE8305918L (sv) Mellanprodukter for framstellning av bensimidazolderivat
MY105571A (en) Herbicidal 1,3,5-triazin-2-ylaminocarbonylamino- sulfonylbenzoic esters, the preparation and use thereof.
ES470296A1 (es) Mejoras introducidas en un procedimiento para la preparacionde fluormetal-aminoacidos
DK379281A (da) Azolylalkyl-derivater fremgangsmaade til deres fremstilling og deres anvendelse som fungicider
ES8609482A1 (es) Un metodo para producir acido dihidrodesoxigriseolico y sa- les y esteres del mismo
IE780279L (en) Imidazole derivatives
IE780926L (en) Chromene derivatives
JPS5225740A (en) Preparation of o-acyl-amidinophenols or acid addition salts thereof
DK364386D0 (da) 1-alkyl-ergolinyl-thiourinstofderivater og fremgangsmaade til fremstilling deraf samt deres anvendelse
YU119491A (sh) Novi protivirusni tetrahidroimidazo [1,4] benzodiazepin-2-(ti)oni i postupak njihovog dobijanja
NO164170C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzhydryl-4-cinnamyl-piperazinderivater.
EP0472325A3 (en) Acid addition salts of an optically active alaninanilide compound and pharmaceutical compositions containing the same
EP0392015A4 (en) Novel derivatives of physiologically active substance ml-236b and process for their preparation